• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

US Adolescent E-cigarette Users at Increased Risk for COVID-19

Slideshow

A new survey found adolescents who have ever used e-cigarettes are 5-times more likely to receive a COVID-19 diagnosis. More results at-a-glance in our new slideshow.

Researchers from Stanford University and the University of California recently published results of their new study in the Journal of Adolescent Health which examined whether US adolescent e-cigarette smokers were more likely to experience coronavirus disease 2019 (COVID-19)-related symptoms, be tested for, and/or diagnosed with COVID-19. Scroll through the slides below for more study details and key takeaways for primary care.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
©vinnstock/Shutterstock.com

Antivirals for Influenza Underutilized Among Vulnerable Children, Adolescents

Grace Halsey
November 20th 2024
Article

Analysis of surveillance data revealed a decline in use of antiviral medications for children hospitalized with influenza and prevalent underprescribing in outpatient settings.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Awareness of Lung Cancer Screening Extremely Low Among Those at Highest Risk in the US: New Data /image credit Gerard Silvestri, MD, MS, courtesy of Hollings Cancer Center

Awareness of Lung Cancer Screening Extremely Low Among Those at Highest Risk in the US: New Data

Grace Halsey
November 18th 2024
Article

Among current smokers, 71% had never spoken a clinician about screening and among those who had quit, 75% had never had a conversation.

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

Sydney Jennings
October 25th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with American Academy of Family Physicians Board Chair Sterling Ransone, Jr, MD.

Pandemic Medical Misinformation Has Not Prompted Disciplinary Action, Study Reveals image credit Richard S Saver, JD, University of North Carolina School of law

Pandemic Medical Misinformation Has Not Prompted Disciplinary Action, Study Reveals

Richard Payerchin
November 13th 2024
Article

Little action has been taken by state medical boards against clinicians who spread unsubstantiated claims about COVID-19, vaccines, or other pandemic-related topics.

FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine / Image credit: ©Kateryna_Kon/AdobeStock

FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine

Sydney Jennings
November 12th 2024
Article

The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.

© 2024 MJH Life Sciences

All rights reserved.